MOLECULAR DIFFERENCES BETWEEN MYELOID LINEAGE NEOPLASMS (ACUTE MYELOID LEUKAEMIA, MYELODYSPLASTIC SYNDROMES AND MYELOPROLIFERATIVE NEOPLASMS) AND THEIR CLINICAL IMPLICATIONS

被引:0
|
作者
Gonzalez, A. [1 ]
Alvarez, N. [1 ]
Morales, M. L. [1 ]
Carreno, G. [2 ]
Onecha, E. [1 ]
Sanchez, R. [1 ]
Espino, M. J. [2 ]
Tejero, F. [2 ]
Linares, M. [2 ]
Martinez, P. [1 ]
Cedena, T. [3 ]
Rapado, I [2 ]
Martinez-Lopez, J. [2 ]
Ayala, R. [1 ]
机构
[1] Inst Invest Hosp 12 Octubre I 12, Unidad Invest Clin Tumores Hematol H12O CNIO, Dept Hematol Traslac, CIBERONC, Madrid, Spain
[2] Hosp 12 Octubre, Serv Hematol, Dept Hematol Traslac, Madrid, Spain
[3] Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol, Madrid, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CO-060
引用
收藏
页码:44 / 45
页数:2
相关论文
共 50 条
  • [1] Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
    Sud, Amit
    Chattopadhyay, Subhayan
    Thomsen, Hauke
    Sundquist, Kristina
    Sundquist, Jan
    Houlston, Richard S.
    Hemminki, Kari
    BLOOD, 2018, 132 (09) : 973 - 976
  • [2] The Diagnostic Utility of a Myeloid Mutational Panel for Myelodysplastic Syndromes and Myelodysplastic/myeloproliferative Neoplasms
    Ibrar, Warda
    Cox, Jesse
    Amador, Catalina
    Qureishi, Hina
    Fu, Kai
    Greiner, Timothy
    Vokoun, Allison
    Zhang, Weiwei
    Ji, Yuan
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1310 - 1310
  • [3] The Diagnostic Utility of a Myeloid Mutational Panel for Myelodysplastic Syndromes and Myelodysplastic/myeloproliferative Neoplasms
    Ibrar, Warda
    Cox, Jesse
    Amador, Catalina
    Qureishi, Hina
    Fu, Kai
    Greiner, Timothy
    Vokoun, Allison
    Zhang, Weiwei
    Ji, Yuan
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1310 - 1310
  • [4] Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms
    Patel, Bhumika
    Hirsch, Cassandra
    Clemente, Michael
    Sekeres, Mikkael
    Makishima, Hideki
    Maciejewski, Jaroslaw P.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (03) : 213 - 218
  • [5] Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms
    Bhumika Patel
    Cassandra Hirsch
    Michael Clemente
    Mikkael Sekeres
    Hideki Makishima
    Jaroslaw P. Maciejewski
    International Journal of Hematology, 2015, 101 : 213 - 218
  • [6] Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
    Bjorkholm, Magnus
    Derolf, Asa R.
    Hultcrantz, Malin
    Kristinsson, Sigurdur Y.
    Ekstrand, Charlotta
    Goldin, Lynn R.
    Andreasson, Bjorn
    Birgegard, Gunnar
    Linder, Olle
    Malm, Claes
    Markevarn, Berit
    Nilsson, Lars
    Samuelsson, Jan
    Granath, Fredrik
    Landgren, Ola
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) : 2410 - 2415
  • [7] Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology
    Della Porta, Matteo G.
    Bewersdorf, Jan Philipp
    Wang, Yu-Hung
    Hasserjian, Robert P.
    HISTOPATHOLOGY, 2025, 86 (01) : 158 - 170
  • [8] Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
    Wan, Ziqi
    Han, Bing
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [9] Molecular and cytogenetic abnormalities in acute myeloid leukaemia and myelodysplastic syndromes
    deGreef, GE
    Hagemeijer, A
    BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (01): : 1 - 18
  • [10] MOLECULAR ALTERATIONS ASSOCIATED WITH PROGRESSION OF MYELODYSPLASTIC SYNDROMES TO MYELODYSPLASTIC SYNDROMES/MYELOPROLIFERATIVE NEOPLASMS
    Valencia, A.
    Masala, E.
    Buchi, F.
    Sanna, A.
    Gozzini, A.
    Contini, E.
    Torricelli, F.
    Przychodzen, B.
    Maciejewski, J. P.
    Bosi, A.
    Santini, V.
    HAEMATOLOGICA, 2015, 100 : 54 - 54